MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/jtd-2026-0776

Медицинская библиотека · Journal of thoracic disease · 2026

Retrospective cohort study on prognostic factors of malignant pleural effusion secondary to pleural mesothelioma.

Qiao Xin, Zhang Jing-Jing, Liu Bin, Qin Jian-Wen

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Malignant pleural effusion (MPE) frequently complicates pleural mesothelioma; however, prognostic determinants for this condition, particularly pleural fluid biomarkers, have yet to be comprehensively characterized. This study sought to assess the prognostic utility of clinical profiles and laboratory findings, with a specific focus on pleural fluid parameters, in patients with mesothelioma-associated MPE.

METHODS

This retrospective cohort study included patients diagnosed with MPE secondary to pleural mesothelioma at Tianjin Chest Hospital from January 2015 to May 2025. Inclusion criteria: age ≥18 years, confirmed diagnosis. Exclusion criteria: active infection, incomplete baseline clinical/laboratory data, or prior anti-tumor therapy. Follow-up was conducted via telephone at monthly intervals for 6 months then every 3 months. The primary outcome was overall survival (OS), defined as time from diagnosis to death or last follow-up. Univariable and multivariable Cox regression analyses were performed to identify independent prognostic factors.

RESULTS

Seventy‑one eligible patients were analyzed. Median OS was 30 months (range, 16-44 months). Four factors were independently associated with OS in multivariable analysis: pleural fluid lactate dehydrogenase (LDH) ≥361 U/L [hazard ratio (HR) 4.373, 95% confidence interval (CI): 1.903-10.049, P=0.001], fibrinogen (FIB) ≥3.82 g/L (HR 3.592, 95% CI: 1.683-7.666, P=0.001), mean platelet volume (MPV) ≥12.50 fL (HR 2.507, 95% CI: 1.125-5.586, P=0.03), and absolute lymphocyte count ≥1.48×109/L (HR 0.423, 95% CI: 0.204-0.877, P=0.02).

CONCLUSIONS

These four routinely available baseline parameters-pleural fluid LDH, FIB, MPV, and absolute lymphocyte count-may serve as potential prognostic indicators in patients with MPE secondary to pleural mesothelioma. Prospective, multicenter studies with external validation are required to confirm these findings.

Для цитирования: Qiao Xin, Zhang Jing-Jing, Liu Bin, Qin Jian-Wen. Retrospective cohort study on prognostic factors of malignant pleural effusion secondary to pleural mesothelioma.. Journal of thoracic disease. 2026. DOI: 10.21037/jtd-2026-0776.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.